Targeting MXD1 Sensitises Pancreatic Cancer to Trametinib

By
Jamie Kang
-
0
73
Scientists illustrated the mechanisms of resistance to trametinib in PDAC and identified trametinib resistance-associated druggable targets, thus improving the treatment efficacy of trametinib-resistant PDAC.
[Gut]
Abstract